ArticleFrontiers in pharmacology2024

'Risk-benefit' assessment for comprehensive safety evaluation of Chinese patent medicines containing four common toxic ingredients: an analysis of clinical risk factors.

Nan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.